Life Technologies | LIFE - Cost Of Sales



Life Technologies reported 15.38M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Ardelyx USD 14.82M 3.44M Jun/2025
Biogen USD 605M 24.3M Jun/2025
Bristol-Myers Squibb USD 3.37B 339M Jun/2025
Cipla INR 24.23B 2.34B Jun/2025
Clal Biotechnology ILS 16.49M 2.64M Jun/2022
Compugen USD 1.66M 985K Jun/2025
CSL USD 3.93B 527M Dec/2024
Galapagos EUR 4.71M 9.02M Jun/2025
GlaxoSmithKline GBP 2.16B 241M Jun/2025
Grifols EUR 1.21B 143.12M Dec/2024
Life Technologies 15.38M 15.38M Jun/2025
Novartis USD 3.32B 95M Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024
United Therapeutics USD 175.2M 102.3M Jun/2025